Elanco completes $1.3B sale of aqua business, allowing it to reduce debt load
The company had debt of $5.7 billion as of March 31 and has been under pressure from Wall Street to reduce it.
Health Care & Life Sciences
Articles
Lilly to buy Massachusetts biopharma company for $3.2B
Massachusetts-based Morphic Holding Inc. is a nine-year old, publicly traded company that is developing a class of drugs known as oral integrin therapies to treat autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases and cancer.
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
The decision also could affect other major bankruptcies, including the $2.4 billion bankruptcy plan for the Boy Scouts of America that has been approved by a federal judge, lawyers said.
Franciscan Alliance sued by Indy physician for breach of contract, interfering in practice
Dr. Greg Hardin, an orthopedic surgeon who specializes in sports medicine, claims that Franciscan Alliance engaged in conduct harmful to his practice over the course of several years.
Hamilton County hospital surge comes amid closings elsewhere
Community Health Network’s announcement this month that it plans to open a $335 million campus near U.S. 31 and 196th Street in Westfield marks the latest entry into the crowded Hamilton County hospital market.
2024 Innovation Issue: How automation can be a lifesaver
Lilly plans to outfit its Lebanon plants—now under construction—with the latest in robotic, digital manufacturing equipment that will do much of the work that a generation ago was done by humans.
Marion County health care agencies plan east-side investments
This summer, the Health and Hospital Corporation of Marion County will break ground on a multiyear, $170 million facilities improvement plan—the largest investment in the agency’s structures in decades—beginning with a new public health lab.
Nuclear medicine booms in central Indiana
The roster of radiopharmaceuticals players in the Indianapolis area has surged in the past few years to include some of the world’s leading pharmaceutical companies, attracted by the potential for significant growth.
Fishers neighbors create medical record app
Primary Record allows families and other caregivers to organize and share medical information with one another and with doctors from their computer or phone.
Patients on hunt for diabetes, obesity and weight-loss drugs
Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood sugar and take off weight.
Surgeons from across the U.S. come to Indiana Spine Group to learn the latest techniques
The Carmel medical group is gaining a reputation as a training and education center. It holds courses for high school and college students in anatomy as well as surgeons going out on their own after residencies and fellowships.
Ascension health care system retracts nationwide—but not in Indy
In the past five years, the nation’s largest Catholic health system has unloaded more than a dozen hospitals across the country, from New York to Alabama, as it restructures amid a growing tide of red ink.
Health care providers dig out from ransomware attack
A Feb. 21 cyberattack against a Nashville, Tennessee-based medical-billing clearinghouse sent shock waves across Indiana’s health care system.
Elanco reaches agreement with activist investor, avoiding messy proxy fight
The Greenfield-based maker of animal vaccines, antibiotics and other health products said that as part of the agreement with Ancora Holding Inc., it will appoint two new independent directors supported by the investment firm to its board.
Businesses prepare for eclipse-related complications, disruptions
Some local workplaces’ plans include everything from shifting delivery and staffing schedules to paring back operations to working remotely—or even taking the day off.
Elanco digs in for fight with activist investor
Ancora Holdings Inc. is pushing for a shakeup in leadership at he Greenfield-based animal health company, which it accuses of delivering poor margins, sluggish product commercialization, negative shareholder returns and poor governance policies.
Lilly employees have seen big wins as stock price surges 500% since 2019
In the past 52 weeks, shares have set new records almost every week, due to investor eagerness over the company’s new drugs for obesity and diabetes, two health conditions that plague America, along with other drugs in the pipeline.
With overhaul looming, organ network pushes to reduce wait times
The Indiana Donor Network, which serves 85 of Indiana’s 92 counties, is booming with a record number of registered donors and transplanted organs.
As Lilly stock skyrockets, endowment gifts surge
In recent weeks, the Indianapolis-based philanthropy has been unveiling a flurry of gifts at the $100 million level or higher.
Lilly sees fourth-quarter profit jump 13%, with strong demand for Mounjaro and Zepbound
The Indianapolis based drugmaker posted net income of $2.19 billion for the quarter. Excluding nonrecurring items, adjusted earnings per share of $2.49 beat the FactSet consensus of $2.30.